CSS
FHTX icon

Cubist Systematic Strategies’s Foghorn Therapeutics FHTX Stock Holding History

Cubist Systematic Strategies’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,895
Closed -$51.4K – 3056
2024
Q4 		$51.4K Buy
+10,895
New +$79.4K ﹤0.01% 2783
2023
Q1 		– Sell
-1,400
Closed -$8.93K – 4053
2022
Q4 		$8.93K Buy
+1,400
New +$10.6K ﹤0.01% 4054
2022
Q3 		– Sell
-209
Closed -$3K – 4513
2022
Q2 		$3K Sell
209
-8,944
-98% -$115K ﹤0.01% 4309
2022
Q1 		$139K Sell
9,153
-12,183
-57% -$167K ﹤0.01% 3151
2021
Q4 		$488K Buy
+21,336
New +$307K ﹤0.01% 2464

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cubist Systematic Strategies's FHTX Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Foghorn Therapeutics (FHTX) in Q1 2025, closing a stake of 10,895 shares — an estimated $51.4K sold.

Cubist Systematic Strategies first reported a position in FHTX in Q4 2021 and held it in 5 quarters. The position peaked at $488K in Q4 2021. 90 funds tracked by Wall St. Rank hold FHTX as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Foghorn Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 10,895 Foghorn Therapeutics shares in Q1 2025, an estimated $51.4K.
  • Cubist Systematic Strategies first reported a position in Foghorn Therapeutics in Q4 2021 and held it in 5 quarters.
  • Cubist Systematic Strategies's Foghorn Therapeutics position peaked at $488K in Q4 2021.
  • 90 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.